Site networks are undergoing a meaningful shift.
What were once loosely connected groups of investigators are evolving into more structured, operationally unified organizations designed to deliver greater consistency, scalability, and performance for sponsors.
In a recent feature by Dan Schell in Clinical Leader, Tekton Research CEO Corey Collins shares perspective on how this transformation is reshaping the clinical trial landscape – and what it means for sponsors, sites, and patients.
Read the Full Article: To explore the full perspective, read the original feature on ClinicalLeader.com.